31st BioCity Symposium regsitration is open!
This year BioCity Symposium is arranged on-site in Mauno Conference Centre, BioCity, together with InFLAMES Research Flagship 25–26 August 2022, with the title Solution is in Immunity.
This year’s program includes eleven talks from international scientists spiced up with short talks from Finnish researchers, and the list of speakers is outstanding. Keynote speaker of the Symposium is Sir Peter J. Ratcliffe who will give a talk about the hypoxia work which lead to his 2019 Nobel Prize in Physiology and Medicine. Since the event is arranged together with InFLAMES Research Flagship several excellent immunologists are invited to give a talk, among which Professor Eugene Butcher from Stanford University, who will talk about vascular control of immune cell traffic. This year BioCity Symposium will include a panel discussion about the role of biotech in the development of new medicines, where Jeffrey Bluestone from Sonoma Biotherapeutics Inc. will discuss about the topic with the audience.
Send your poster abstract at latest Friday 3 June at 16:00
Researchers are encouraged to participate to the poster exhibition and submit a poster abstract when registering to the event at latest Friday 3 June 2022 at 16:00 (CET +1). Based on the submitted abstracts four researchers are invited to give a short talk in the Symposium. Registration to the event closes Thursday 11 August 2022 at 23:59 (CET +1) and the Symposium is free of charge.
Registration:
https://biocityturku.fi/biocity-symposium/registration/
Details about the abstract and posters:
https://biocityturku.fi/biocity-symposium/call-for-poster-abstracts/
Program and list of speakers:
https://biocityturku.fi/program/
For more information:
Maija Lespinasse, BioCity Turku coordinator, 040 5658 654, biocityturku@bioscience.fi
Recent Posts
- Dissertation Defence: Eleftheria MaranouMSc Eleftheria Maranou, from affiliated MIORG group, succesfully defended the dissertation in Immunology titled “The Achilles’ heel of Read moreSeptember 1, 2026
- Researchers discover molecular mechanism that helps aggressive colorectal cancer to spreadResearchers from the University of Turku in Finland, Turku Bioscience Centre and Gustave Roussy Institute Read moreAugust 25, 2026
- The Novo Nordisk Foundation has awarded funding of approximately one million euros to a research project led by Professor Jukka WestermarckThe Novo Nordisk Foundation has awarded funding of approximately one million euros to a research Read moreAugust 21, 2026
- Early-career researchers invited to BioCity Pre-Symposium on 26 August.Doctoral researchers at BioCity Turku are organising a pre-symposium on 26 August 2026, offering early-career Read moreApril 30, 2026
- 35th BioCity Symposium is arranged 27–28 August 2026.This year, BioCity Symposium is arranged on-site in Mauno Koivisto Centre, BioCity in 27–28 August Read moreApril 14, 2026
- Turku Protein Core Opens Two New PositionsTurku Protein Core (TuProtCore) is seeking to fill two roles: a Project Specialist in Service Read moreApril 7, 2026